Andrew Oterson
814 N. Market St. Frederick, MD 21701 • CELL: 412-606-2255 •
@andyoterson • •
Summary of Qualifications
Award winning, creative sales/marketing professional with experience which includes pharmaceutical and medical device sales along with a vast knowledge of social media. A self-motivated starter with a history of consistently exceeding goals. Skilled in: marketing analysis, networking, cold calling, brand initiatives and product launches. Professional Experience

Medical Device Regional Account Executive
iScreen Vision Inc.- Mid-Atlantic Region
Promoted an FDA cleared medical device in an 8 state territory, making cold calls on pediatricians, pediatric ophthalmologist, and optometrists. Provided guidance to iScreen Vision on pricing strategies, marketing and promotional brochure design. Created territory business plan, and marketing strategy designed to educate customers on the value of early vision screening and drive vision screener sales.  #2 ranked national performer  Customized and optimized iScreen Vision’s Salesforce CRM
Transitions Social Media LLC.
Founded and implemented a brand, eatbytweet, that focuses on using social media to aggregate and organize niche restaurant information. Created a real-time search engine for restaurant specials and reservations information using the Twitter API. Managed developers to ensure project completion. Performed market analysis along with developed brand initiatives and strategic affiliations. Networked to meet the most influential social media mavens and industry leaders.  Guest lectured at the University of Maryland on Social Media  Eatbytweet was featured on
Pharmaceutical Sales Representative
Aqua Pharmaceuticals- Washington DC/ Baltimore Territory
Educated and promoted to dermatologists three dermatological product lines to increase sales and market share. Knowledge of specific dermatology markets such as acne, steroids and actinic keratoses. Created and implemented territory business plan, including: routing, call cycle, and budget allocation.  Monodox Capsules – Increased volume by over 200% since date of hire  Cordran Topicals- Increased market share of combined lotion and cream totals by 4.9% o Cordran Cream- Highest market share amongst full time employees when o Cordran Lotion- Achieved six straight quarters of consistent growth o Cordran Tape- Second highest market share in the company. Highest volume in  Fluoroplex Cream- Amongst leaders in market share growth
Pharmaceutical Sales Representative
FlavorX- U.S. Territory
Detailed pediatricians and primary care physicians on flavoring for liquid medications, throughout the entire United States. Trained pharmacists on the proper procedures to dispense FlavorX. Taught pharmacists the best ways to market FlavorX. Knowledge of specific drugs and how they are affected by our products. Arranging all of the travel and procedural plans, effectively minimizing company expenses.  Awarded Two Appreciation of Achievement Certificates  Reorder sales, which are a result of the detailing teams’ effort, had increased over 60% Customer Sales Representative
Kraft/Nabisco Division- Columbus, OH
Managed 14 high volume accounts in the Columbus, OH territory. Managed merchandisers to ensure completion of daily activities. Involved in all aspects of what happened to the Nabisco product after it entered each store.  Increased year-to-date sales by 8.3%  Achieved 8 straight months of bonuses for exceeding projected numbers  Awarded Customer Sales Representative for Quarter 2 of the Columbus Office Education
INDIANA UNIVERSITY, Bloomington, IN (1998-2002) BS from the Kelley School of Business, Marketing, with a G.P.A. 3.25/4.0


Pii: s0955-2863(99)00008-x

Feeding the nitric oxide synthase inhibitor L-N ␻ nitroarginine elevates serum very low density lipoprotein and hepatic triglyceride synthesis in rats Tsuyoshi Goto,* Shoko Ohnomi,* Abdelkrim Khedara,* Norihisa Kato,* Hiroshi Ogawa,† and Teruyoshi Yanagita‡ *Department of Applied Biochemistry, Hiroshima University, Higashi-Hiroshima, Japan;†Department of Hygiene, Kinki University

(microsoft word - \305rsrapport 2005.doc)

% endring av legemiddelkj øp % endring i pris per DDD SAMMENDRAG UNN kjøpte legemidler for kr 95,4 mill i 2005. Dette utgjorde en økning på 13,9%, 11,7 mill. kroner, i forhold til 2004. Volumendringen utgjorde en økning på 6,5 % mens pris per dose økte med 7 %. Den totale rabatten som er oppnådd gjennom Legemiddelinnkjøpssamarbeidet utgjorde i 2005 17,7 mill

Copyright ©2018 Sedative Dosing Pdf